![Michael Weiser](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Weiser
Directeur/Membre du Conseil chez
EMISPHERE TECHNOLOGIES, INC.
Fortune : 578 576 $ au 31/05/2026
Profil
Michael Weiser was the founder of Foresight Biotherapeutics, Inc. (2008, Chief Executive Officer & Director), Actin Biomed LLC (2006, Co-Chairman), and Actin Capital LLC (2006, Co-Chairman).
Current jobs include Independent Director at Emisphere Technologies, Inc. (since 2005), Independent Director at Iovance Biotherapeutics, Inc. (since 2018), and Member of the American Society of Clinical Oncology, Inc., Alpha Omega Alpha Honor Medical Society, American Society of Hematology, The Association for Research in Vision & Ophthalmology, and The National Medical Honor Society.
Former jobs include Chairman at Ivory Capital Corp., Chairman at Chelsea Therapeutics International Ltd. (2012-2014), Director at VioQuest Pharmaceuticals, Inc. (2003-2009), Director of Research at Paramount BioCapital Asset Management, Inc. (2001-2002), Director at TG Therapeutics, Inc. (2003-2010), Research Director at Paramount BioCapital, Inc. (1998-2006), Director at ZIOPHARM, Inc. (2003-2005), Director at Alacrity Biosciences, Inc., Director at Talon Therapeutics, Inc. (2002-2010), Independent Director at Alaunos Therapeutics, Inc. (2005-2018), Research Director at Paramount BioSciences LLC (2006), Executive Vice President at Paramount Acquisition Corp.
(2005-2008), and President & Secretary at Seward Sciences, Inc. (2008).
Education includes an undergraduate degree from the University of Vermont (1987), a doctorate from Weill Cornell Medical College, and a doctorate from New York University School of Medicine (1996).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 141 116 ( 0,03% ) | 578 576 $ | 31/05/2026 |
Postes actifs de Michael Weiser
| Sociétés | Poste | Début |
|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/01/2005 |
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/03/2018 |
Alpha Omega Alpha Honor Medical Society
 Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Operates as medical organization | Corporate Officer/Principal | - |
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Corporate Officer/Principal | 22/02/2010 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 22/02/2010 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | 22/02/2010 |
Actin Biomed LLC
 Actin Biomed LLC Investment ManagersFinance Acts as an alternative investment manager | Fondateur | 21/07/2011 |
The National Medical Honor Society | Corporate Officer/Principal | - |
Actin Capital LLC | Fondateur | 14/09/2009 |
Anciens postes connus de Michael Weiser
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Weiser
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
VioQuest Pharmaceuticals, Inc.
 VioQuest Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops early clinical-stage therapies for metabolic, inflammatory diseases and cancer | Health Technology |
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Paramount BioCapital Asset Management manages hedge funds and private equity funds that focus on investments in healthcare and life sciences companies. The firm invests globally, with emphasis on the stocks of small-cap healthcare technology companies. | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ivory Capital Corp.
 Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Finance |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager | Finance |
ZIOPHARM, Inc.
 ZIOPHARM, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Investment vehicle acquiring operating businesses in the healthcare industry | Finance |
Seward Sciences, Inc.
 Seward Sciences, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Alacrity Biosciences, Inc.
 Alacrity Biosciences, Inc. Medical DistributorsDistribution Services Develops and markets pharmaceutical products | Distribution Services |
Foresight Biotherapeutics, Inc.
 Foresight Biotherapeutics, Inc. BiotechnologyHealth Technology Develops drugs and therapies for eyes and ears diseases | Health Technology |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Alpha Omega Alpha Honor Medical Society
Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Operates as medical organization | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount invests in companies located in the United States. The firm focuses on companies operating in the fields of biotechnology, pharmaceutical development, healthcare and life-sciences sectors. | Finance |
Actin Biomed LLC
Actin Biomed LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
Actin Capital LLC | |
The Association for Research in Vision & Ophthalmology
The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Commercial Services |
The National Medical Honor Society | |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
